Back to YC Companies
Granza Bio
Winter 2024
Active
Building programmable therapeutics for the immune system
8 people View on YC
Granza Bio at a glance
- Y Combinator batch
- Winter 2024
- Status
- Active
- Industry
- Healthcare
- Team size
- 8 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Granza Bio
Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.
Tags:
Synthetic Biology
Biotech
Healthcare
Therapeutics
Oncology